These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25794429)

  • 1. The association of PLA2G2A single nucleotide polymorphisms with type IIa secretory phospholipase A2 level but not its activity in patients with stable coronary heart disease.
    Shuvalova YA; Khasanova ZB; Kaminnaya VI; Samoilova EV; Korotaeva AA; Rubanovich AV; Kaminnyi AI
    Gene; 2015 Jun; 564(1):29-34. PubMed ID: 25794429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PLA2G2A polymorphisms are associated with metabolic syndrome and type 2 diabetes mellitus. Results from the genetics of atherosclerotic disease Mexican study.
    Monroy-Muñoz IE; Angeles-Martinez J; Posadas-Sánchez R; Villarreal-Molina T; Alvarez-León E; Flores-Dominguez C; Cardoso-Saldaña G; Medina-Urrutia A; Juárez-Rojas JG; Posadas-Romero C; Alarcon GV
    Immunobiology; 2017 Oct; 222(10):967-972. PubMed ID: 27608594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of two PLA2G2A variants associated with secretory phospholipase A2-IIA levels.
    Exeter HJ; Folkersen L; Palmen J; Franco-Cereceda A; Cooper JA; Kalea AZ; Hooft FV; Eriksson P; Humphries SE; Talmud PJ
    PLoS One; 2012; 7(7):e41139. PubMed ID: 22879865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tagging SNP haplotype analysis of the secretory PLA2-V gene, PLA2G5, shows strong association with LDL and oxLDL levels, suggesting functional distinction from sPLA2-IIA: results from the UDACS study.
    Wootton PT; Arora NL; Drenos F; Thompson SR; Cooper JA; Stephens JW; Hurel SJ; Hurt-Camejo E; Wiklund O; Humphries SE; Talmud PJ
    Hum Mol Genet; 2007 Jun; 16(12):1437-44. PubMed ID: 17545304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study.
    Holmes MV; Simon T; Exeter HJ; Folkersen L; Asselbergs FW; Guardiola M; Cooper JA; Palmen J; Hubacek JA; Carruthers KF; Horne BD; Brunisholz KD; Mega JL; van Iperen EPA; Li M; Leusink M; Trompet S; Verschuren JJW; Hovingh GK; Dehghan A; Nelson CP; Kotti S; Danchin N; Scholz M; Haase CL; Rothenbacher D; Swerdlow DI; Kuchenbaecker KB; Staines-Urias E; Goel A; van 't Hooft F; Gertow K; de Faire U; Panayiotou AG; Tremoli E; Baldassarre D; Veglia F; Holdt LM; Beutner F; Gansevoort RT; Navis GJ; Mateo Leach I; Breitling LP; Brenner H; Thiery J; Dallmeier D; Franco-Cereceda A; Boer JMA; Stephens JW; Hofker MH; Tedgui A; Hofman A; Uitterlinden AG; Adamkova V; Pitha J; Onland-Moret NC; Cramer MJ; Nathoe HM; Spiering W; Klungel OH; Kumari M; Whincup PH; Morrow DA; Braund PS; Hall AS; Olsson AG; Doevendans PA; Trip MD; Tobin MD; Hamsten A; Watkins H; Koenig W; Nicolaides AN; Teupser D; Day INM; Carlquist JF; Gaunt TR; Ford I; Sattar N; Tsimikas S; Schwartz GG; Lawlor DA; Morris RW; Sandhu MS; Poledne R; Maitland-van der Zee AH; Khaw KT; Keating BJ; van der Harst P; Price JF; Mehta SR; Yusuf S; Witteman JCM; Franco OH; Jukema JW; de Knijff P; Tybjaerg-Hansen A; Rader DJ; Farrall M; Samani NJ; Kivimaki M; Fox KAA; Humphries SE; Anderson JL; Boekholdt SM; Palmer TM; Eriksson P; Paré G; Hingorani AD; Sabatine MS; Mallat Z; Casas JP; Talmud PJ
    J Am Coll Cardiol; 2013 Nov; 62(21):1966-1976. PubMed ID: 23916927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type II secretory phospholipase A2 and prognosis in patients with stable coronary heart disease: mendelian randomization study.
    Breitling LP; Koenig W; Fischer M; Mallat Z; Hengstenberg C; Rothenbacher D; Brenner H
    PLoS One; 2011; 6(7):e22318. PubMed ID: 21799821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of 5'UTR polymorphism of secretory phospholipase A2 group IIA (PLA2G2A) gene with prostate cancer metastasis.
    Ozturk K; Onal MS; Efiloglu O; Nikerel E; Yildirim A; Telci D
    Gene; 2020 Jun; 742():144589. PubMed ID: 32179174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an Allele-Specific Transcription Factor Binding Interaction that May Regulate PLA2G2A Gene Expression.
    Hara A; Lu E; Johnstone L; Wei M; Sun S; Hallmark B; Watkins JC; Zhang HH; Yao G; Chilton FH
    Bioinform Biol Insights; 2024; 18():11779322241261427. PubMed ID: 39081667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Group IIA Secretory Phospholipase A
    Akinkuolie AO; Lawler PR; Chu AY; Caulfield M; Mu J; Ding B; Nyberg F; Glynn RJ; Ridker PM; Hurt-Camejo E; Chasman DI; Mora S
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1182-1190. PubMed ID: 31070471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tagging-SNP haplotype analysis of the secretory PLA2IIa gene PLA2G2A shows strong association with serum levels of sPLA2IIa: results from the UDACS study.
    Wootton PT; Drenos F; Cooper JA; Thompson SR; Stephens JW; Hurt-Camejo E; Wiklund O; Humphries SE; Talmud PJ
    Hum Mol Genet; 2006 Jan; 15(2):355-61. PubMed ID: 16368710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphism of Secretary PLA2G2A Gene Associated with Its Serum Level in Type2 Diabetes Mellitus Patients in Northern Iran.
    Khajeniazi S; Marjani A; Shakeri R; Hakimi S
    Endocr Metab Immune Disord Drug Targets; 2019; 19(8):1192-1197. PubMed ID: 31132981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum secretory phospholipase A2-IIa (sPLA2-IIA) levels in patients surviving acute myocardial infarction.
    Xin H; Chen ZY; Lv XB; Liu S; Lian ZX; Cai SL
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):999-1004. PubMed ID: 23661511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of single nucleotide polymorphisms in the prostaglandin-endoperoxide synthase 2 (PTGS2) and phospholipase A₂ group IIA (PLA2G2A) genes with susceptibility to esophageal squamous cell carcinoma.
    Liu F; Wei WQ; Cormier RT; Zhang ST; Qiao YL; Li XQ; Zhu ST; Zhai YC; Peng XX; Yan YX; Wu LJ; He D; He Y
    Asian Pac J Cancer Prev; 2014; 15(4):1797-802. PubMed ID: 24641411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an allele-specific transcription factor binding interaction that regulates
    Hara A; Lu E; Johnstone L; Wei M; Sun S; Hallmark B; Watkins JC; Zhang HH; Yao G; Chilton FH
    bioRxiv; 2023 Dec; ():. PubMed ID: 38168258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue.
    Tribler L; Jensen LT; Jørgensen K; Brünner N; Gelb MH; Nielsen HJ; Jensen SS
    Anticancer Res; 2007; 27(5A):3179-85. PubMed ID: 17970059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Type II Secretory Phospholipase A2 Increases the Risk of Early Atherosclerosis in Patients with Newly Diagnosed Metabolic Syndrome.
    Sun CQ; Zhong CY; Sun WW; Xiao H; Zhu P; Lin YZ; Zhang CL; Gao H; Song ZY
    Sci Rep; 2016 Dec; 6():34929. PubMed ID: 27941821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elevated serum secretory type II phospholipase A2 in patients with coronary heart disease].
    Yu L; Jiang WB; Fu GS; Qin GM; Wang JH; Huang ZQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):812-5. PubMed ID: 17217690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine.
    Fijneman RJ; Cormier RT
    Front Biosci; 2008 May; 13():4144-74. PubMed ID: 18508504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel genetic approach to investigate the role of plasma secretory phospholipase A2 (sPLA2)-V isoenzyme in coronary heart disease: modified Mendelian randomization analysis using PLA2G5 expression levels.
    Holmes MV; Exeter HJ; Folkersen L; Nelson CP; Guardiola M; Cooper JA; Sofat R; Boekholdt SM; Khaw KT; Li KW; Smith AJ; Van't Hooft F; Eriksson P; Franco-Cereceda A; Asselbergs FW; Boer JM; Onland-Moret NC; Hofker M; Erdmann J; Kivimaki M; Kumari M; Reiner AP; Keating BJ; Humphries SE; Hingorani AD; Mallat Z; Samani NJ; Talmud PJ;
    Circ Cardiovasc Genet; 2014 Apr; 7(2):144-50. PubMed ID: 24563418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.